Literature DB >> 33922618

Small GTPases of the Rab and Arf Families: Key Regulators of Intracellular Trafficking in Neurodegeneration.

Alazne Arrazola Sastre1,2, Miriam Luque Montoro1, Hadriano M Lacerda3, Francisco Llavero1,4, José L Zugaza1,2,5.   

Abstract

Small guanosine triphosphatases (GTPases) of the Rab and Arf families are key regulators of vesicle formation and membrane trafficking. Membrane transport plays an important role in the central nervous system. In this regard, neurons require a constant flow of membranes for the correct distribution of receptors, for the precise composition of proteins and organelles in dendrites and axons, for the continuous exocytosis/endocytosis of synaptic vesicles and for the elimination of dysfunctional proteins. Thus, it is not surprising that Rab and Arf GTPases have been associated with neurodegenerative diseases such as Alzheimer's and Parkinson's. Both pathologies share characteristics such as the presence of protein aggregates and/or the fragmentation of the Golgi apparatus, hallmarks that have been related to both Rab and Arf GTPases functions. Despite their relationship with neurodegenerative disorders, very few studies have focused on the role of these GTPases in the pathogenesis of neurodegeneration. In this review, we summarize their importance in the onset and progression of Alzheimer's and Parkinson's diseases, as well as their emergence as potential therapeutical targets for neurodegeneration.

Entities:  

Keywords:  Alzheimer; Arf GTPase; Parkinson; Rab GTPase; membrane trafficking; neurodegeneration; small GTPase; transport; vesicle

Year:  2021        PMID: 33922618     DOI: 10.3390/ijms22094425

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  159 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

Review 2.  CORVET and HOPS tethering complexes - coordinators of endosome and lysosome fusion.

Authors:  Henning J kleine Balderhaar; Christian Ungermann
Journal:  J Cell Sci       Date:  2013-03-15       Impact factor: 5.285

3.  Ecotropic Viral Integration Site 5 (EVI5) variants are associated with multiple sclerosis in Iranian population.

Authors:  Mehrdokht Mazdeh; Soudeh Ghafouri-Fard; Rezvan Noroozi; Arezou Sayad; Maryam Khani; Mohammad Taheri; Mir Davood Omrani
Journal:  Mult Scler Relat Disord       Date:  2017-09-14       Impact factor: 4.339

4.  Rab7 induces clearance of α-synuclein aggregates.

Authors:  Elisabeth Dinter; Theodora Saridaki; Markus Nippold; Sarah Plum; Leonie Diederichs; Daniel Komnig; Luisa Fensky; Caroline May; Katrin Marcus; Aaron Voigt; Jörg B Schulz; Björn H Falkenburger
Journal:  J Neurochem       Date:  2016-08-04       Impact factor: 5.372

5.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 6.  Alzheimer's disease.

Authors:  Jose A Soria Lopez; Hector M González; Gabriel C Léger
Journal:  Handb Clin Neurol       Date:  2019

Review 7.  Role of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy.

Authors:  You-Kyung Lee; Jin-A Lee
Journal:  BMB Rep       Date:  2016-08       Impact factor: 4.778

Review 8.  Molecular control of Rab activity by GEFs, GAPs and GDI.

Authors:  Matthias P Müller; Roger S Goody
Journal:  Small GTPases       Date:  2017-02-01

9.  FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport.

Authors:  Serhiy Pankiv; Endalkachew A Alemu; Andreas Brech; Jack-Ansgar Bruun; Trond Lamark; Aud Overvatn; Geir Bjørkøy; Terje Johansen
Journal:  J Cell Biol       Date:  2010-01-25       Impact factor: 10.539

10.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more
  5 in total

Review 1.  New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases.

Authors:  Wooseon Choi; Shinwon Kang; Jiyoon Kim
Journal:  Arch Pharm Res       Date:  2022-09-30       Impact factor: 6.010

Review 2.  Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer's Disease.

Authors:  Kate L Jordan; David J Koss; Tiago F Outeiro; Flaviano Giorgini
Journal:  Biomedicines       Date:  2022-05-16

Review 3.  Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease.

Authors:  José Ángel Martínez-Menárguez; Emma Martínez-Alonso; Mireia Cara-Esteban; Mónica Tomás
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

4.  Editorial: Neuronal cytoskeleton and GTPases in health and diseases.

Authors:  Cecilia Conde; Emily Anne Bates; Corina Garcia; Oscar M Lazo
Journal:  Front Cell Dev Biol       Date:  2022-09-15

Review 5.  Revising Endosomal Trafficking under Insulin Receptor Activation.

Authors:  Maria J Iraburu; Tommy Garner; Cristina Montiel-Duarte
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.